Semana et al previously found HLA-DR-restricted CD4+ T cell responses to proinsulin peptide C3-16, which overlaps significantly with the region we identify here, in individuals with diabetes but these were not analysed for HLA [20]. The gene discussed is CD4; the disease is diabetes mellitus.